Attention: open in a new window. E-mailPrintPDF
Biomed is investing PLN600,000 in tripling the output capacity for oncological drugs by September 2018, and it is also in talks with potential buyers of rights for the probiotic brand…

Order subscription to read this article

 

Login


Subscribe

Order at PNB.pl
Order from our partners:
E-Kiosk.pl
Nexto.pl


Call us:

Find us: